Thomas C. Merigan

Immunology and Microbiology · Life Sciences

72h-index20.1kcitations276works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(78), HIV/AIDS drug development and treatment(68), HIV/AIDS Research and Interventions(52), Cytomegalovirus and herpesvirus research(41), Herpesvirus Infections and Treatments(35)

Publications276 total

High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, Nigeria
Cureus·2026Open Access
Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection
UNC Libraries·2020Open Access
Cytomegalovirus Retinitis in Immunosuppressed Hosts
Annals of Internal Medicine·2020
Role of Physician-Scientists in the Control of Human Immunodeficiency Virus
The Journal of Infectious Diseases·2018Open Access
In Vitro HIV-1 Evolution in Response to Triple Reverse Transcriptase Inhibitors & In Silico Phenotypic Analysis
PLoS ONE·2013· 7 citedOpen Access
Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance
Viruses·2012· 3 citedOpen Access
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
Nature Medicine·2009· 263 citedOpen Access
Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study
Pharmacogenetics and Genomics·2006· 63 cited
Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects
JAIDS Journal of Acquired Immune Deficiency Syndromes·2006· 160 cited
“Wide-Open” 1.3 Å Structure of a Multidrug-Resistant HIV-1 Protease as a Drug Target
Structure·2005· 98 citedOpen Access
Pharmacogenetics of Long‐Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study
The Journal of Infectious Diseases·2005· 251 cited
Pharmacokinetics of Nelfinavir and Efavirenz in Antiretroviral-Naive, Human Immunodeficiency Virus-Infected Subjects when Administered Alone or in Combination with Nucleoside Analog Reverse Transcriptase Inhibitors
Antimicrobial Agents and Chemotherapy·2005· 12 citedOpen Access
Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms
Antimicrobial Agents and Chemotherapy·2005· 41 citedOpen Access
Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug‐Resistant HIV‐1 Infection
Clinical Infectious Diseases·2005· 120 citedOpen Access
Nonnucleoside Reverse Transcriptase Inhibitor Phenotypic Hypersusceptibility Can Be Demonstrated in Different Assays
JAIDS Journal of Acquired Immune Deficiency Syndromes·2005· 7 cited
New Two-Amino Acid Insertion Near Codon 70 of the HIV Type 1 Protease Gene
AIDS Research and Human Retroviruses·2005· 9 cited
Rare One and Two Amino Acid Inserts Adjacent to Codon 103 of the HIV-1 Reverse Transcriptase (Rt) Affect Susceptibility to Non-Nucleoside Rt Inhibitors
Antiviral Therapy·2005· 4 citedOpen Access
Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, with Protease Inhibitor Therapy and In Vitro Drug Resistance
Antimicrobial Agents and Chemotherapy·2004· 12 citedOpen Access
Human Immunodeficiency Virus Type 1 Infection in Oman: Antiretroviral Therapy and Frequencies of Drug Resistance Mutations
AIDS Research and Human Retroviruses·2004· 7 cited
Human Immunodeficiency Virus Type 1 Infection in Oman: Antiretroviral Therapy and Frequencies of Drug Resistance Mutations
AIDS Research and Human Retroviruses·2004
page 1 of 14Next →

Frequent Co-authors

Richard B. Pollard(8), Martin Hirsch(7), Robert W. Shafer(5), Richard C. Reichman(4), Douglas D. Richman(4), George W. Jordan(4), Gregory K. Robbins(4), Margaret A. Fischl(3), David Katzenstein(3), Mark A. Winters(3), Kenneth H. Rand(3), Victor De Gruttola(3), Laura Smeaton(3), Richard T. D’Aquila(3), Lucille E. Rasmussen(3), David A. Stevens(3), Paul A. Volberding(2), Stephen W. Lagakos(2), Carla Pettinelli(2), Robert L. Murphy(2)